MOF, MOH Form Joint Committee To Tackle Rising Private Healthcare Costs
The committee, which convened its first meeting today, will coordinate a whole-of-nation approach to collaboratively develop and implement measures aligned with value-based healthcare.
The JMCPHC is co-chaired by Finance Minister II Datuk Seri Amir Hamzah Azizan and Health Minister Datuk Seri Dr Dzulkefly Ahmad, with committee members consisting of representatives from MOF, MOH, and Bank Negara Malaysia (BNM).
The committee will be supported with inputs and technical advice by a Consultative Council, comprising representatives from key stakeholders across the private healthcare ecosystem, including private hospitals, insurance providers and Takaful operators (ITOs).
'Rising healthcare costs are a major concern for Malaysians, and the MADANI Government is taking the lead to address it. This joint committee reflects our commitment to work with all stakeholders to shape a private healthcare system that is sustainable, transparent, and delivers real value.
'At its core, this is about protecting the wellbeing of Malaysians and strengthening the resilience of our nation,' Amir Hamzah said in a joint statement by the two ministries today.
He said the JMCPHC builds upon previous groundwork, including BNM's implementation of co-pay requirements, interim measures to cushion the impact of medical premium adjustments for policyholders affected in 2024–2026, and the RESET framework.
It covers five strategic thrusts to address medical inflation, namely: Revamp Medical and Health Insurance/Takaful (MHIT); Enhance price transparency; Strengthen the Digital Health ecosystem; Expand cost-effective options; and Transform provider payments.
RESET is broadly endorsed and supported by MOF, MOH, BNM, and key industry stakeholders as the strategic framework to address rising private healthcare and insurance costs.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Express
43 minutes ago
- Daily Express
Impractical to revive GST now, says Amir Hamzah
Published on: Thursday, July 03, 2025 Published on: Thu, Jul 03, 2025 By: Elill Easwaran, FMT Text Size: Finance minister II Amir Hamzah Azizan said reviving the GST would take at least two years and have a wider economic impact. (Facebook pic) PETALING JAYA: Finance Minister II Amir Hamzah Azizan says the government has ruled out reintroducing the goods and services tax (GST) for now, calling it 'impracticable' under current economic conditions. He said established and new businesses have 'moved on' to alternative tax structures since the GST was zero-rated in 2018. As a result, a full reinstatement of the GST would likely take at least two years, he added. Speaking as a guest on the Keluar Sekejap podcast, Amir said the government has never disputed the merits of the GST system. However, he said Putrajaya was of the view that it cannot be reintroduced as it 'not suitable for now'. 'The GST is broad-based. It will affect everyone,' he said. 'Companies like the GST because of the input-output tax mechanism: what they charge, they can claim back. But, in the end, the burden falls on the people.' Amir said the government was of the view that tax reform must be pragmatic and compatible with Malaysia's current economic structure. 'When we impose a tax, we need to ask: is the revenue we get worth the effort?' he added. Podcast co-host Khairy Jamaluddin said Amir's explanation was acceptable, noting that the minister was not making the case that the sales and service tax (SST) was inherently better that the GST regime. Last month, Prime Minister Anwar Ibrahim said Putrajaya would consider bringing back the tax scheme when the economy improves and the minimum wage reaches RM4,000 or more. For now, the government has expanded the SST to cover more items, with a 5% to 10% tax on non-essential goods and added service tax on rent, construction, financial services, and private healthcare and education. On the distribution of government aid, Amir drew comparisons between the unity government's Sumbangan Tunai Rahmah (STR) and Sumbangan Asas Rahmah (SARA) aid schemes and the 1Malaysia People's Aid or BR1M during Najib Razak's time. He said BR1M had reached RM1,200 at most, while the maximum amount of cash aid a household can receive under STR and SARA is RM4,600. * Follow us on our official WhatsApp channel and Telegram for breaking news alerts and key updates! * Do you have access to the Daily Express e-paper and online exclusive news? Check out subscription plans available. Stay up-to-date by following Daily Express's Telegram channel. Daily Express Malaysia
The Sun
2 hours ago
- The Sun
Top TV Anchors Lead National Stem Cell Awareness Drive
FOUR of Malaysia's most beloved TV news anchors — Gan Jiang Han, Lim She Ting, Tan Ley Teng, and Marsila Hassan — have stepped forward as the first YAKIN AMBASSADORS in a groundbreaking national initiative to demystify and democratise regenerative medicine. Launched by Yakin Splendour Global Holdings Bhd, the strategic brand arm of Yakin Medic Sdn Bhd, the campaign titled 'YAKIN Stem Cell Technology • Now Within Your Reach' is set to reshape how Malaysians understand and access stem cell therapy. At its heart, YAKIN AMBASSADORS is about building trust, sparking meaningful conversations, and showing that regenerative therapy is not only real — it's reachable. 'The vision behind YAKIN AMBASSADORS is to bridge the gap between science and society. 'This initiative is not just about public engagement — it's about sparking meaningful conversations, reducing misconceptions, and inspiring individuals to take control of their health through innovative and proven medical solutions,' said Patrick Tan, founder and chief executive officer of Yakin Group of Companies. Witnessed by Deputy Minister of Science, Technology and Innovation Datuk Mohammad Yusof Apdal, the signing ceremony signaled a pivotal moment for Malaysian healthcare, merging innovation with relatable advocacy. 'This initiative not only offers renewed hope to patients battling chronic and degenerative illnesses but also elevates Malaysia's standing in the field of medical tourism. 'I am proud to see local companies like Yakin Splendour actively transforming the nation's healthcare landscape, in line with the aspirations of the 12th Malaysia Plan and the national science, technology, and innovation agenda,,' said Yusof. A Personal and National Mission Founded in 2014, Yakin Medic has grown from a clinical data unit into one of Malaysia's foremost regenerative and stem cell therapy providers. Today, it offers hope to patients suffering from chronic diseases, age-related conditions, and degenerative illnesses. For Tan, the mission is deeply personal. After surviving third-degree burns in an accident, the very therapies he once advocated became vital to his recovery. 'I believed in the science, but I never imagined I'd become a patient myself. 'That experience changed everything. It became personal. 'Through further research, we found stem cells offered powerful solutions to these widespread health issues. It's one thing to believe in the science. It's another to be saved by it,' Tan explained. In September 2024, Yakin Medic entered into a technical collaboration with China-based IASO Biotherapeutics, combining CAR-T cell technology with regenerative therapies and iTeraCare resonant technology — a strategic move to position Malaysia as a regional biotech leader. Industry Partnerships and Expansion Adding momentum to the campaign, SceneFis Aesthetic, a prominent beauty centre and distributor for Yakin Splendour, has committed over RM400,000 in a strategic alliance. The partnership supports wellness, rejuvenation, and skin health — illustrating the vast potential of stem cell applications in both healthcare and aesthetics. 'We are proud to collaborate with Yakin Group. 'We believe these innovations can benefit many Malaysians seeking wellness and rejuvenation,' said Vesley Lee Siew Khim, Managing Director of SceneFis Aesthetic. A Vision for the Future Yakin Splendour is working to reduce the cost of stem cell therapy through bioreactor-based mass production, aiming to make treatments more affordable in the next two years. But safety and scientific integrity remain top priorities. 'This is a field that can't be rushed. Safety, science, and standards must always come first. 'Real science takes patience. Clinical trials, global standards, consistent quality and all of that matter because lives are at stake,' said Tan. Over the coming months, the YAKIN AMBASSADORS will participate in outreach programmes, community events, and storytelling initiatives that humanize stem cell therapy and offer real-world insight into its benefits. 'This is not just a campaign. It's a movement that uplifts, educates, and connects. 'It's about showing Malaysians that this isn't some distant or elitist science — it's something real, and it's here,' said Datuk Steven Lai, Director of Yakin Splendour Global Holdings Bhd.
The Sun
2 hours ago
- The Sun
Yakin Splendour launches YAKIN AMBASSADORS to bring stem cell therapy into the public sphere
FOUR of Malaysia's most beloved TV news anchors — Gan Jiang Han, Lim She Ting, Tan Ley Teng, and Marsila Hassan — have stepped forward as the first YAKIN AMBASSADORS in a groundbreaking national initiative to demystify and democratise regenerative medicine. Launched by Yakin Splendour Global Holdings Bhd, the strategic brand arm of Yakin Medic Sdn Bhd, the campaign titled 'YAKIN Stem Cell Technology • Now Within Your Reach' is set to reshape how Malaysians understand and access stem cell therapy. At its heart, YAKIN AMBASSADORS is about building trust, sparking meaningful conversations, and showing that regenerative therapy is not only real — it's reachable. 'The vision behind YAKIN AMBASSADORS is to bridge the gap between science and society. 'This initiative is not just about public engagement — it's about sparking meaningful conversations, reducing misconceptions, and inspiring individuals to take control of their health through innovative and proven medical solutions,' said Patrick Tan, founder and chief executive officer of Yakin Group of Companies. Witnessed by Deputy Minister of Science, Technology and Innovation Datuk Mohammad Yusof Apdal, the signing ceremony signaled a pivotal moment for Malaysian healthcare, merging innovation with relatable advocacy. 'This initiative not only offers renewed hope to patients battling chronic and degenerative illnesses but also elevates Malaysia's standing in the field of medical tourism. 'I am proud to see local companies like Yakin Splendour actively transforming the nation's healthcare landscape, in line with the aspirations of the 12th Malaysia Plan and the national science, technology, and innovation agenda,,' said Yusof. A Personal and National Mission Founded in 2014, Yakin Medic has grown from a clinical data unit into one of Malaysia's foremost regenerative and stem cell therapy providers. Today, it offers hope to patients suffering from chronic diseases, age-related conditions, and degenerative illnesses. For Tan, the mission is deeply personal. After surviving third-degree burns in an accident, the very therapies he once advocated became vital to his recovery. 'I believed in the science, but I never imagined I'd become a patient myself. 'That experience changed everything. It became personal. 'Through further research, we found stem cells offered powerful solutions to these widespread health issues. It's one thing to believe in the science. It's another to be saved by it,' Tan explained. In September 2024, Yakin Medic entered into a technical collaboration with China-based IASO Biotherapeutics, combining CAR-T cell technology with regenerative therapies and iTeraCare resonant technology — a strategic move to position Malaysia as a regional biotech leader. Industry Partnerships and Expansion Adding momentum to the campaign, SceneFis Aesthetic, a prominent beauty centre and distributor for Yakin Splendour, has committed over RM400,000 in a strategic alliance. The partnership supports wellness, rejuvenation, and skin health — illustrating the vast potential of stem cell applications in both healthcare and aesthetics. 'We are proud to collaborate with Yakin Group. 'We believe these innovations can benefit many Malaysians seeking wellness and rejuvenation,' said Vesley Lee Siew Khim, Managing Director of SceneFis Aesthetic. A Vision for the Future Yakin Splendour is working to reduce the cost of stem cell therapy through bioreactor-based mass production, aiming to make treatments more affordable in the next two years. But safety and scientific integrity remain top priorities. 'This is a field that can't be rushed. Safety, science, and standards must always come first. 'Real science takes patience. Clinical trials, global standards, consistent quality and all of that matter because lives are at stake,' said Tan. Over the coming months, the YAKIN AMBASSADORS will participate in outreach programmes, community events, and storytelling initiatives that humanize stem cell therapy and offer real-world insight into its benefits. 'This is not just a campaign. It's a movement that uplifts, educates, and connects. 'It's about showing Malaysians that this isn't some distant or elitist science — it's something real, and it's here,' said Datuk Steven Lai, Director of Yakin Splendour Global Holdings Bhd.
